Hedge Funds & Alternative Investments
Uncategorized
Egypt: HoldiPharma receives 5 investment bank offers for subsidiary EGX listings
The state-owned pharmaceutical firm HoldiPharma has received five offers from investment banks to manage the anticipated offerings of its subsidiaries, Chemical Industries Development and Misr Pharma, on the Egyptian Exchange (EGX), government sources told Al Borsa News. HoldiPharma is studying the offers, and is set to decide upon a bank…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: Zawya